瑞典公司发射EpiFinderTM基因组Pro,这是用于疾病和药物研究的高通量前导分析工具。 Swedish firm launches EpiFinder™ GenomePro, a high-throughput epigenetic analysis tool for disease and drug research.

瑞典生命科学公司Epiogenda AB启动了EpiFinderTM基因组Pro,这是一个新工具,有助于对直方修改和DNA甲基化进行高通量、多路分析。 Epigenica AB, a Swedish life sciences company, has launched the EpiFinder™ GenomePro, a new tool enabling high-throughput, multiplexed analysis of histone modifications and DNA methylation. 该平台建立在专有的hmqChIP技术基础上,每运行一次处理多达24个样本,产生多达192个全基因组的ChIP-Seq概况,投入极少,成本降低,数据质量高。 Built on proprietary hmqChIP technology, the platform processes up to 24 samples per run, generating up to 192 genome-wide ChIP-Seq profiles with minimal input, reduced costs, and high data quality. 它支持灵活配置,并包括一个开放源码分析管道。 It supports flexible configuration and includes an open-source analysis pipeline. 其目的是加速对疾病、药物研制和精密医学的遗传研究。 Designed for scalability, it aims to accelerate epigenetic research in disease, drug development, and precision medicine.